Neurotech Pharmaceuticals’ surgically implanted cell and gene therapy, Encelto, is now FDA approved to treat macular telangectasia type 2 (MacTel). It’s the first therapy for this rare retinal degeneration disorder. The post Gene Therapy in an Implant: Neurotech Lands First FDA Approval in Rare Vision Disorder appeared first on MedCity News.
Healthcare organizations are starting to implement AI agents — autonomous, task-specific systems designed to perform functions with little or no human intervention. While initial adoption is focused mainly on non-clinical areas like scheduling and prior authorizations, experts predict that AI agents could eventually play a role in clinical decision-making, provided they meet rigorous safety and…
With Sunrise’s women’s health program, the company can support women battling sleep issues due to conditions like pregnancy, polycystic ovary syndrome, perimenopause, menopause and premenstrual syndrome. The post Sunrise Introduces Sleep Offering Tailored to Women appeared first on MedCity News.
Providing affordable point-of-care diagnostic tools can be instrumental in quickly and efficiently assessing the well-being of all people, especially pregnant mothers. This can empower healthcare providers to be better diagnosticians and improve overall patient care, particularly for those at risk. The post Navigating Diagnostic Deserts: How Portable Ultrasound is Improving Maternal Healthcare in Africa appeared…
While the drop in drug overdose deaths is promising, and could potentially be partially attributed to the efforts of the federal government, we must remain cognizant about the sheer number of lives we continue to lose every year to overdose. The post Buprenorphine Access Still Lags, Even After Major Federal Policy Changes appeared first on…
Lavonia Thomas, nursing informatics officer at MD Anderson Cancer Center, hopes that nurses will gain more access to ambient listening tools that listen in on patient conversations and then generate summaries for documentation purposes. These AI tools have become popular among physicians in the past couple years. The post This Hospital Exec Wants Nurses Should…
J&J said aticaprant showed insufficient efficacy in a Phase 3 test in major depressive disorder. The disappointing result follows the Phase 3 failure of a Neumora Therapeutics drug that addresses the same central nervous system target. The post Johnson & Johnson Discontinues Pivotal Depression Drug Trial Due to Lack of Efficacy appeared first on MedCity…
[Sponsored] MedCity News Editor in Chief Arundhati Parmar moderated a webinar with Elation Health executives Dr Sara Pastoor, head of primary care advancement, and Meaghan Sullivan, senior sales engineer. The post How Can EHRs Support the Shift to Value-Based Care and Reduce Clinician Burnout? appeared first on MedCity News.
GEM HEALTH’s Series A round was co-led by HealthTrend Capital and LFE Capital and included participation from existing investors Base10 Partners and Mairs & Power Venture Capital. The post GEM HEALTH Secures $7M to Advance Virtual Sleep Care appeared first on MedCity News.
How do we tip the scale to lower the rate of denials? While AI has been the initial decision-maker for years, it must become better trained. And to do that, it needs help. The post Better AI + Correct Provider Guidance = Fewer Denials appeared first on MedCity News.